EP Patent

EP2808015A1 — Compositions comprising nebivolol

Assigned to Mylan Inc · Expires 2014-12-03 · 11y expired

What this patent protects

The active ingredients of the pharmaceutical composition described consist of nebivolol, one or more ACE inhibitors and one or more ARB.

USPTO Abstract

The active ingredients of the pharmaceutical composition described consist of nebivolol, one or more ACE inhibitors and one or more ARB.

Drugs covered by this patent

Patent Metadata

Patent number: EP2808015A1
Jurisdiction: EP
Classification: —
Expires: 2014-12-03
Drug substance claim: No
Drug product claim: No
Assignee: Mylan Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.